ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 40 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,293,000 | -35.8% | 2,350,000 | 0.0% | 0.00% | – |
| Q3 2020 | $2,013,000 | -1.0% | 2,350,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,033,000 | -0.7% | 2,350,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,047,000 | +15.9% | 2,350,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,766,000 | -48.7% | 2,350,000 | -46.6% | 0.00% | – |
| Q3 2019 | $3,443,000 | -21.4% | 4,400,000 | -14.6% | 0.00% | -100.0% |
| Q2 2019 | $4,381,000 | -3.6% | 5,150,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,545,000 | +6.7% | 5,150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,261,000 | -52.1% | 5,150,000 | -51.2% | 0.00% | 0.0% |
| Q3 2018 | $8,904,000 | +15.9% | 10,550,000 | +32.7% | 0.00% | 0.0% |
| Q2 2018 | $7,683,000 | +10.5% | 7,950,000 | +3.9% | 0.00% | 0.0% |
| Q1 2018 | $6,953,000 | -11.1% | 7,650,000 | +12.5% | 0.00% | 0.0% |
| Q4 2014 | $7,824,000 | -26.1% | 6,800,000 | -33.3% | 0.00% | 0.0% |
| Q3 2014 | $10,583,000 | – | 10,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |